Cargando…

Programmed Death-Ligand 1 (PD-L1) Expression Associated with a High Neutrophil/Lymphocyte Ratio in Cholangiocarcinoma

BACKGROUND: Effective treatments for cholangiocarcinoma (CCA) are still lacking. There are promising results of checkpoint inhibitor programmed cell death ligand-1 (PD-L1) activities in early phase trials. This study aimed to investigate the expression of PD-L1 and its relation to possible treatment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sangkhamanon, Sakkarn, Jongpairat, Piangpen, Sookprasert, Aumkhae, Wirasorn, Kosin, Titapun, Attapol, Pugkhem, Ake, Ungareevittaya, Piti, Chindaprasirt, Jarin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	West Asia Organization for Cancer Prevention 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373788/ https://www.ncbi.nlm.nih.gov/pubmed/28670887 http://dx.doi.org/10.22034/APJCP.2017.18.6.1671

Ejemplares similares

Programmed death‑ligand 1 expression in tumor cells and tumor‑infiltrating lymphocytes are associated with depth of tumor invasion in penile cancer
por: Sangkhamanon, Sakkarn, et al.
Publicado: (2023)

Frailty Syndrome in Biliary Tract Cancer Patients: Prevalence and Associated Factors
por: Limpawattana, Panita, et al.
Publicado: (2019)

The impact of skeletal muscle mass on survival outcome in biliary tract cancer patients
por: Limpawattana, Panita, et al.
Publicado: (2018)

Prognostic Factors for Penile Cancer and Survival in Response to Multimodality Therapy
por: Sirithanaphol, Wichien, et al.
Publicado: (2020)

Preoperative controlling nutritional status (CONUT) score is an independent prognostic factor in cholangiocarcinoma patients treated with hepatectomy
por: Titapun, Attapol, et al.
Publicado: (2023)

Breast Cancer Incidence Trends and Projections in Northeastern Thailand
por: Virani, Shama, et al.
Publicado: (2018)

Malignant Mesothelioma of the Pericardium: A Report of Two Different Presentations
por: Makarawate, Pattarapong, et al.
Publicado: (2013)

Prevalence of Geriatric Syndromes in Elderly Cancer Patients Receiving Chemotherapy
por: Limpawattana, Panita, et al.
Publicado: (2020)

Inhibitory effect of NVP-BKM120 on cholangiocarcinoma cell growth
por: Padthaisong, Sureerat, et al.
Publicado: (2018)

MR imaging findings of a patient with isolated intrahepatic splenosis mistaken for hepatocellular carcinoma
por: Somsap, Kulyada, et al.
Publicado: (2016)

Cancer-Associated Fibroblast-Derived IL-6 Determines Unfavorable Prognosis in Cholangiocarcinoma by Affecting Autophagy-Associated Chemoresponse
por: Thongchot, Suyanee, et al.
Publicado: (2021)

Perioperative outcomes in elderly patients undergoing nephrectomy for renal cell carcinoma
por: Sirithanaphol, Wichien, et al.
Publicado: (2019)

Validation of the Thai version of the family reported outcome measure (FROM-16)© to assess the impact of disease on the partner or family members of patients with cancer
por: Chantarasap, Pattariya, et al.
Publicado: (2019)

Chemotherapeutic resistant cholangiocarcinoma displayed distinct intratumoral microbial composition and metabolic profiles
por: Sitthirak, Sirinya, et al.
Publicado: (2022)

Interleukin-6-derived cancer-associated fibroblasts activate STAT3 pathway contributing to gemcitabine resistance in cholangiocarcinoma
por: Kittirat, Yingpinyapat, et al.
Publicado: (2022)

In vitro and in vivo Anti-Tumor Effects of Pan-HER Inhibitor Varlitinib on Cholangiocarcinoma Cell Lines
por: Dokduang, Hasaya, et al.
Publicado: (2020)

Diagnostic and Prognostic Value of Circulating Cell-Free DNA for Cholangiocarcinoma
por: Wintachai, Preawwalee, et al.
Publicado: (2021)

Group versus modified individual standard-setting on multiple-choice questions with the Angoff method for fourth-year medical students in the internal medicine clerkship
por: Senthong, Vichai, et al.
Publicado: (2013)

Prognostic Factors for Large Symptomatic Gists: a Pragmatic Study of Experiences From a University Hospital Over 10 Years
por: Prasertcharoensuk, Supatcha, et al.
Publicado: (2017)

Modification of the eighth AJCC/UICC staging system for perihilar cholangiocarcinoma: An alternative pathological staging system from cholangiocarcinoma-prevalent Northeast Thailand
por: Aphivatanasiri, Chaiwat, et al.
Publicado: (2022)

Infrahepatic Inferior Vena Cava Clamping Reduces Blood Loss during Liver Transection for Cholangiocarcinoma
por: Leeratanakachorn, Natwutpong, et al.
Publicado: (2021)

Inhibition of endothelial nitric oxide synthase in cholangiocarcinoma cell lines – a new strategy for therapy
por: Suksawat, Manida, et al.
Publicado: (2018)

Predictive utility of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in intraductal papillary neoplasm of the bile duct
por: Luvira, Vor, et al.
Publicado: (2019)

Prognostic Significance of Growth Pattern in Predicting Outcome of Opisthorchis viverrini-Associated Distal Cholangiocarcinoma in Thailand
por: Kunprom, Waritta, et al.
Publicado: (2022)

Prognostic significance of tumor-infiltrating lymphocytes in predicting outcome of distal cholangiocarcinoma in Thailand
por: Intarawichian, Piyapharom, et al.
Publicado: (2022)

Re-Rising of Total Bilirubin Level after Postoperative Day 3 (The V Pattern) Predicting Liver Failure and Survival of Patients who Underwent Hepatectomy for Cholangiocarcinoma
por: Sawangkajohn, Weerin, et al.
Publicado: (2020)

Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinoma
por: Padthaisong, Sureerat, et al.
Publicado: (2020)

Suppression of 14-3-3ζ in cholangiocarcinoma cells inhibits proliferation through attenuated Akt activity, enhancing chemosensitivity to gemcitabine
por: Kittirat, Yingpinyapat, et al.
Publicado: (2018)

Serum Apurinic/Apyrimidinic Endodeoxyribonuclease 1 (APEX1) Level as a Potential Biomarker of Cholangiocarcinoma
por: Tummanatsakun, Doungdean, et al.
Publicado: (2019)

Compliance with enhanced recovery after surgery predicts long-term outcome after hepatectomy for cholangiocarcinoma
por: Jongkatkorn, Chaowasaporn, et al.
Publicado: (2023)

Mismatch Repair Deficiency Is a Prognostic Factor Predicting Good Survival of Opisthorchis viverrini-Associated Cholangiocarcinoma at Early Cancer Stage
por: Khuntikeo, Natcha, et al.
Publicado: (2023)

Evaluation of p53 and Its Target Gene Expression as Potential Biomarkers of Cholangiocarcinoma in Thai Patients
por: Puetkasichonpasutha, Janpen, et al.
Publicado: (2020)

Interleukin 25 (IL-25) expression in cholangiocarcinoma
por: Kaewsarabhumi, Supakit, et al.
Publicado: (2020)

The Impact of Pre-analytical Quality Initiatives on Cholangiocarcinoma Diagnostics in Thailand
por: Koonmee, Supinda, et al.
Publicado: (2022)

A panel of protein kinase high expression is associated with postoperative recurrence in cholangiocarcinoma
por: Padthaisong, Sureerat, et al.
Publicado: (2020)

Establishment of a Potential Serum Biomarker Panel for the Diagnosis and Prognosis of Cholangiocarcinoma Using Decision Tree Algorithms
por: Kimawaha, Phongsaran, et al.
Publicado: (2021)

In vitro and molecular chemosensitivity in human cholangiocarcinoma tissues
por: Suksawat, Manida, et al.
Publicado: (2019)

Bladder Malakoplakia in Systemic Sclerosis Patient: A Case Report and Review Literature
por: Sirithanaphol, Wichien, et al.
Publicado: (2018)

Apoptosis-Inducing Factor, Mitochondrion-Associated 3 (AIFM3) Protein Level in the Sera as a Prognostic Marker of Cholangiocarcinoma Patients
por: Chua-on, Daraporn, et al.
Publicado: (2020)

Zileuton suppresses cholangiocarcinoma cell proliferation and migration through inhibition of the Akt signaling pathway
por: Khophai, Sasikamon, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_auuucdnfsr87jgkftgseocq6q8